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PKC-epsilon is an important intracellular signaling mole-
cule in primary afferent nociceptors, implicated in acute
and chronic inflammatory as well as neuropathic pain. In
behavioral experiments the inflammatory mediator
epinephrine produces PKC-epsilon-dependent hyperalge-
sia only in male rats. The mechanism underlying this sex-
ual dimorphism is unknown. We show that the hormone
environment of female rats changes the nociceptive sign-
aling in the peripheral sensory neuron. This change is
maintained in culture also in the absence of a gender-sim-
ulating environment. Addition of estrogen to male-
derived DRG neurons produces a switch to the female
phenotype, namely abrogation of beta 2-AR-initiated acti-
vation of PKC-epsilon. Estrogen interferes downstream of
the beta 2-AR with the signaling pathway leading from
Epac to PKC-epsilon. The interfering action is fast indicat-
ing a transcription-independent mechanism.
As in other systems, estrogen has a dual effect. If applied
minutes before beta 2-AR or Epac stimulation, estrogen
abrogates the activation of PKC-epsilon. In contrast, estro-
gen applied alone leads to a brief translocation of PKC-
epsilon. Also in vivo the activity of estrogen depends on
the stimulation context. Intradermal injection of an Epac
activator as well as estrogen alone induces mechanical
hyperalgesia through a PKC-epsilon-dependent mecha-
nism. In contrast, injection of estrogen preceeding the
activation of Epac completely abrogates the Epac-induced
mechanical hyperalgesia.
Our results indicate that gender differences in nociception
do not reflect the use of generally different mechanisms.
Instead, the contribution of a common set of signaling
pathways can be modulated by hormones.
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